April 29, 2020 / 7:58 AM / a month ago

BRIEF-Destiny Pharma Says Patient Recruitment For Xf-73 Phase 2B Trial Temporarily Paused Due To Covid-19 Pandemic

April 29 (Reuters) - Destiny Pharma PLC:

* DESTINY PHARMA PLC - PATIENT RECRUITMENT FOR XF-73 PHASE 2B TRIAL TEMPORARILY PAUSED DUE TO COVID-19 PANDEMIC

* DESTINY PHARMA PLC - REMAINS WELL FUNDED TO EXECUTE ON ITS BUSINESS STRATEGY AND TO PROGRESS ITS LEAD AND FOLLOW-ON PROGRAMMES IN 2020 AND 2021

* DESTINY PHARMA PLC - BASIC AND DILUTED LOSS PER SHARE FOR YEAR WAS 10.7 PENCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below